findmyKOL

Dinesh Keerty, MD

Basic profile

Louisiana State University in Shreveport

ORCIDNPI
RegionSpring Hill, FL · SoutheastSpecialtyMedical OncologyFocusOncology
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2023Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Dinesh Keerty is an Oncology physician affiliated with Louisiana State University in Shreveport. OpenAlex indexes 21 publications with 306 citations (h-index 7).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
21publications

Distinct works indexed by OpenAlex, matched via ORCID.

306citations

Total citations across indexed works.

7h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
54companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

11063 County Line Rd
Spring Hill, FL 346095696

Telephone

352-688-7744

Provider last certified this registry record 9 Jul 2025.

View the NPPES registry record

Industry payments

54 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Nervous system

    31.7%
    Opioid Agonist12.3%
    Oxycodone Hcl73%Oxycodone-Acetaminophen27%
    Part D<11 patients
    Gabapentinoids9.5%
    Gabapentin100%
    Part D13 patients

    + 2 more classes in this area

  • Metabolism & gastrointestinal

    24.1%
    Serotonin-3 Receptor Antagonist9.5%
    Ondansetron Odt100%
    Part D18 patients
    Corticosteroid6.4%
    Prednisone100%
    Part D15 patients

    + 2 more classes in this area

  • Cancer & immunology

    12.6%
    Cytochrome P450 17A1 Inhibitor4.5%
    Abiraterone Acetate100%
    Part D<11 patients
    Anti-androgens4.2%
    Nubeqa100%
    Part D<11 patients

    + 1 more class in this area

Where care is delivered (Part B), 2022100% facility · 0% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”